Grifols (GRFS) Cash & Equivalents (2009 - 2025)
Grifols (GRFS) reported Cash & Equivalents of $969.15 million for the quarter ended Dec 31, 2025, down 5.0% from $1.02 billion a year earlier.
Powered by 
Analysis
Grifols (GRFS) Cash & Equivalents (2009 - 2025) Analysis & Trends
Dating back to the quarter ended Dec 31, 2009, Grifols' Cash & Equivalents record includes 42 quarters.
- Cash & Equivalents has a five-year compound annual growth rate of 6.3% (years ended Dec 2020 to Dec 2025).
- By year, Cash & Equivalents came in at $1.02 billion in the year ended Dec 31, 2024 (+74.2%), $585.51 million in the year ended Dec 31, 2023 (unchanged), $585.28 million in the year ended Dec 31, 2022 (-80.7%) and $3.03 billion in the year ended Dec 31, 2021 (+325.1%).
- The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Cash & Equivalents since the quarter ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Grifols | 5.96 Bn | 5.04 Bn | - | 969.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 969.15 Mn |
| Dec 31, 2024 | 1.02 Bn |
| Dec 31, 2023 | 585.51 Mn |
| Dec 31, 2022 | 585.28 Mn |
| Dec 31, 2021 | 3.03 Bn |
| Dec 31, 2020 | 712.96 Mn |
| Sep 30, 2020 | 1.21 Bn |
| Mar 31, 2020 | 703.41 Mn |
| Dec 31, 2019 | 831.19 Mn |
| Sep 30, 2019 | 866.81 Mn |
| Mar 31, 2019 | 647.65 Mn |
| Dec 31, 2018 | 1.18 Bn |
| Sep 30, 2018 | 677.30 Mn |
| Jun 30, 2018 | 772.98 Mn |
| Mar 31, 2018 | 1.04 Bn |
| Dec 31, 2017 | 1.06 Bn |
| Jun 30, 2017 | 858.37 Mn |
| Dec 31, 2016 | 946.50 Mn |
| Sep 30, 2016 | 1.01 Bn |
| Jun 30, 2016 | 898.05 Mn |
API Access
Grifols Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GRFS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GRFS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GRFS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();